Your browser doesn't support javascript.
loading
Combination of intravitreal bevacizumab and peripheral photocoagulation: an alternative treatment in eales disease.
Cp, Juarez; Al, Gramajo; Jd, Luna.
Afiliação
  • Cp J; Department of Ophthalmology, Centro de Ojos Romagosa-Fundación VER, Córdoba, Argentina.
  • Al G; Department of Ophthalmology, Centro de Ojos Romagosa-Fundación VER, Córdoba, Argentina.
  • Jd L; Department of Ophthalmology, Centro de Ojos Romagosa-Fundación VER, Córdoba, Argentina.
Med Hypothesis Discov Innov Ophthalmol ; 2(2): 30-4, 2013.
Article em En | MEDLINE | ID: mdl-24600639
To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) was injected intravitreously for the treatment of iris and retinal neovascularization in a 56-year old Hispanic female with photocoagulation treatment to control the recurrence of vitreous haemorrhage. Our results revealed that stabilization of the disease and improvement in visual acuity were achieved without any signs of recurrence. Intravitreal bevacizumab in combination with photocoagulation treatment of ischemic retinal areas may be a good alternative for patients with recurrent vitreous haemorrhage due to Eales disease.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med Hypothesis Discov Innov Ophthalmol Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Argentina País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med Hypothesis Discov Innov Ophthalmol Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Argentina País de publicação: Estados Unidos